4//SEC Filing
Martell Christopher 4
Accession 0001209191-22-053831
CIK 0001841387other
Filed
Oct 16, 8:00 PM ET
Accepted
Oct 17, 4:42 PM ET
Size
10.4 KB
Accession
0001209191-22-053831
Insider Transaction Report
Form 4
Martell Christopher
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-10-13+14,240→ 14,240 totalExercise: $2.81Exp: 2032-10-13→ Common Stock (14,240 underlying)
Footnotes (1)
- [F1]This option is subject to time-based vesting. The shares underlying this option shall vest and become exercisable upon the earlier of (i) October 13, 2023 or (ii) the date of the next Annual Meeting of Stockholders of the Company; provided, however, that all vesting shall cease if the Reporting Person resigns from the Board of Directors of the Company or otherwise ceases to serve as a Director, unless the Board determines that the circumstances warrant continuation of vesting.
Issuer
Candel Therapeutics, Inc.
CIK 0001841387
Entity typeother
Related Parties
1- filerCIK 0001873465
Filing Metadata
- Form type
- 4
- Filed
- Oct 16, 8:00 PM ET
- Accepted
- Oct 17, 4:42 PM ET
- Size
- 10.4 KB